Session 3B: Freedom to operate in medtech: how to innovate without IP headaches
Tracks
Track 2
| Wednesday, May 20, 2026 |
| 3:40 PM - 4:25 PM |
Overview
Sponsored by: FB RICE
Details
Freedom to Operate (FTO) is essential for medtech companies aiming to commercialise new technologies without unexpected legal or financial setbacks. This session will unpack how to navigate competitor patents, manage IP risks, and keep product development and investment plans on track. Hear practical insights from experts in IP strategy, commercialisation, and legal on avoiding disputes and strengthening your market position.
Session sponsor:
Speaker
Simon Graindorge
Head of Commercialisation and Business Development
The Kids Research Institute Australia
Panellist
Helen Mutimer
Head of IP Strategy
FB Rice
Panellist
